Amisulpride: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Amisulpride. Educational only — not medical advice.
Labeled uses
BARHEMSYS® is indicated in adults for: prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class. treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
Source: FDA labeling via NIH DailyMed (set ab23bc6e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.